| 1 |
廖 晨，余祖滨，张 萍，等. 慢性阻塞性肺疾病合并肺癌122例临床特征分析[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(1): 30-34.
|
| 2 |
任成山，白 莉，钱桂生. 慢性阻塞性肺疾病合并肺癌临床特征及新理念[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(2): 137-142.
|
| 3 |
de Torres JP, Marín JM, Casanova C, et al. Lung cancer in patients with chronic obstructive pulmonary disease incidence and predicting factors[J]. Am J Respir Crit Care Med, 2011, 184(8): 913-919.
|
| 4 |
Koshiol J, Rotunno M, Consonni D, et al. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study[J]. PLoS One, 2009, 4(10): e7380.
|
| 5 |
Lowry KP, Gazelle GS, Gilmore ME, et al. Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease : A decision analysis[J]. Cancer, 2015, 121(10): 1556-1562.
|
| 6 |
Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial[J]. Ann Intern Med, 2005, 142(4): 233-239.
|
| 7 |
秦茵茵，周承志，张筱娴，等. 原发性支气管肺癌合并慢性阻塞性肺疾病患者的临床研究[J]. 中国呼吸与危重监护志，2013, 12(1): 65-68.
|
| 8 |
Aldrich TK, Vossbrinck M, Zeig-owens RA, et al. Lung function trajectories in world trade Center-Exposed New York city firefighters over 13 years the roles of smoking and smoking cessation[J]. Chest, 2016, 149(6): 1419-1427.
|
| 9 |
Wang F, Ni SS, Liu H. Pollutional haze and COPD: etiology, epidemiology, pathogenesis, pathology, biological markers and therapy[J]. JThorac Dis, 2016, 8(1): E20-E30.
|
| 10 |
Nelson KE, Hersh AL, Nkoy FL, et al. Primary care physician smoking screening and counseling for patients with chronic disease[J]. Prey Med, 2015, 71: 77-82.
|
| 11 |
Pezzuto A, Stumbo L, Russano M, et al. "Impact of smoking cessation treatment" on lung function and response rate in EGFR mutated patients：a short term cohort study[J]. Recent Pat Anticancer Drug Discov, 2015, 10(3): 342-351.
|
| 12 |
Malhotra D, Thimmulappa RK, Mercado N, et al. Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients[J]. J Clin Invest, 2011, 121(11): 4289-4302 .
|
| 13 |
Mateu-Jimenez M, Curull V, Rodriguez-Fuster A, et al. Profile of epigenetic mechanisms in lung tumors of patients with underlying chronic respiratory conditions[J]. Clin Epigenetics, 2018, 10: 7.
|
| 14 |
Provinciali M, Cardelli M, Marchegiani F. Inflammation, chronic obstructive pulmonary disease and aging[J]. Curr Opin Pulm Med, 2011, 17(Suppl 1): S3-S10 .
|
| 15 |
黄 怡，杨佩兰. miR-146 a在呼吸系统疾病中的作用机制的研究进展[J]. 临床肺科杂志，2015, 20(4): 714-719.
|
| 16 |
胡亭亭，肖祖克. miRNAs在慢性阻塞性肺疾病中的研究进展[J]. 临床与病理杂志，2016, 36(7): 1018-1023.
|
| 17 |
Yang I, Wu D, Chen J, et al. A functional CNVR-3425.1damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese[J]. Carcinogenesis, 2018, 39(3): 347-359.
|
| 18 |
Sawa K, Koh Y, Kawaguchi T, et al. PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: a comprehensive mutational analysis from a multi-institutional cohort[J]. Lung Cancer, 2017, 112: 96-101.
|
| 19 |
Teramoto S. Recent progress in genetic background of chronic obstructive pulmonary disease (COPD)[J]. Nihon Rinsho, 2016, 74(5): 733-742.
|
| 20 |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
|
| 21 |
Sinden NJ, Baker MJ, Smith DJ, et al. α-1-antitrypsin variants and the proteinase/ antiproteinase imbalance in chronic obstructive pulmonary disease[J] . Am J Physiol Lung Cell Mol Physiol, 2015, 308(2): L179-L190.
|
| 22 |
陈开宇，江丽萍，陈盛新，等. 慢性阻塞性肺疾病的药物治疗进展[J]. 药学实践杂志，2012, 30(6): 408-411.
|
| 23 |
Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECI.IPSE cohort[J]. Respir Res, 2010, 11: 122.
|
| 24 |
Moghaddam SJ, Li H, Cho SN, et al. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model[J] . Am J Respir Cell Mol Biol, 2009, 40(4): 443-453.
|
| 25 |
Binkley MS, King MT, Shrager JB, et al. Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung[J]. Radiother Oncol, 2017, 123(2): 270-275.
|
| 26 |
Durham AL, Adcock IM. The relationship between COPD and lung cancer[J] . Lung Cancer, 2015, 90(2): 121-127.
|
| 27 |
Sadr M, Noori Mugahi SM, Hassanzadeh G, et al. Telomere shortening in blood leukocytes of patients with chronic obstructive pulmonary disease[J]. Tanaffos, 2015, 14(1): 10-16.
|
| 28 |
Xing YF, Xu YH, Shi MH, et al. The impact of PM 2.5 on the human respiratory system[J]. J Thorac Dis, 2016, 8(1): E69-E74.
|
| 29 |
Wang F, Ni SS, Liu H. Pollutional haze and COPD: etiology, epidemiology, pathogenesis, pathology, biological markers and therapy[J]. J Thorac Dis, 2016, 8(1): E20-E30.
|
| 30 |
Houghton AM. Mechanistic links between COPD and lung cancer[J]. Nat Rev Cancer, 2013, 13(4): 233-245.
|
| 31 |
Kondo R, Yoshida K, Eguchi T, et al. Clinical features of lung cancer in smokers with light and mild chronic obstructive pulmonary disease: a retrospective analysis of Japanese surgical cases[J]. Eur J Cardiothorac Surg, 2011, 40: 1439-1443.
|
| 32 |
Palma D, Lagerwaard F, Rodrigues G, et al. Curative treatment of stage I nonsmall-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review[J]. Int J Radiat Oncol Biol Phys, 2012, 82: 1149-1156.
|
| 33 |
Filippi AR, Franco P, Ricardi U. Is stereotactic ablative radiotherapy an alternative to surgery in operable stage Ⅰnon-small cell lung cancer? [J] . Rep Pract Oncol Radiother, 2013, 19(4): 275-279.
|
| 34 |
Omote N, Hashimoto N, Morise M, et al. Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy[J]. Int J Chron Obstruct Pulmon Dis, 2017, 12: 3541-3547.
|
| 35 |
胡 洁，白春学. 肺癌的规范化治疗[J] . 内科急危重症杂志，2014, 20(5): 294-298.
|
| 36 |
Mitsudomi T, Morita S, Yatabe Y, et al. Gefitinib versus cisplatin plus docetaxel in patients with non-smal-l cell lung cancer harbouring mutations of the epidermal growth factor receptor( WJTOG3405): an open label, randomised phase 3 trial[J]. Lancet Oncol, 2010, 11(2): 121-128.
|
| 37 |
Maemondo M, Inoue A, Kobayashi K, et al. Gefitinib or chemotherapy for Non-Smal-l Cell lung cancer with mutated EGFR[J]. N Engl J Med, 2010, 362(25): 2380-2388.
|
| 38 |
刘盼盼，黄玉蓉. COPD合并肺结核的研究进展[J]. 国际呼吸杂志，2016, 36(23): 1824-1828.
|
| 39 |
Liu SF, Kuo HC, Lin MC, et al. Inhaled corticosteroids have aprotective effect against lung cancer in female patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study[J]. Oncotarget, 2017, 8(18): 29711-29721.
|
| 40 |
Raymakers AJ, McCormick N, Marra CA, et al. Do inhaled corticosteroids protect against lung cancer in patients with COPD？A systematic review[J]. Respirology, 2017, 22(1): 61-70.
|